|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 111, Issue 18 2741-2751, Copyright © 1998 by Company of Biologists
JOURNAL ARTICLES |
Z Nikolova, V Djonov, G Zuercher, AC Andres and A Ziemiecki
Department of Clinical Research, University of Berne, Tiefenaustrasse 120, CH-3004 Berne, Switzerland.
Morphogenesis of the mammary gland occurs mainly during adult life and is dependent on a complex interplay of hormonal, cell-cell and cell-matrix interactions. The molecular mechanisms involved in pattern formation of the mammary epithelium in adult life are poorly understood. Recently, several members of the Eph family of receptor tyrosine kinases and their ligands have been shown to participate in pattern formation during embryogenesis and conceivably may fulfill similar functions during adult morphogenesis. We have investigated the expression of a member of this family, EphB4, and its cognate ligand, ephrin-B2, during normal and malignant mouse mammary morphogenesis. A spatially, temporarily and hormonally coordinated expression of both the receptor and ligand was observed. The receptor was predominantly localized in the myoepithelial cells surrounding the ducts and alveoli whereas ligand expression was limited to the luminal epithelial cells. Expression of both was induced at the onset of gland morphogenesis at puberty and was differentially regulated during the estrus cycle. Ovariectomy of pre-pubertal or adult females abolished the expression of both receptor and ligand and administration of estrogen alone was sufficient to restore their normal expression. Disruption of the balanced expression was observed during experimental mouse mammary carcinogenesis. Ligand expression was lost at the onset of tumorigenesis and receptor expression shifted from myoepithelial to epithelial cells with progressive malignancy. These results implicate both the EphB4 receptor and its ligand ephrin-B2 in the hormone dependent morphogenesis of the mammary gland. Furthermore, their deregulated expression may contribute to mammary carcinogenesis.
This article has been cited by other articles:
|
|
 |
|
  S. Alam, J Fujimoto, I Jahan, E Sato, and T Tamaya Overexpression of ephrinB2 and EphB4 in tumor advancement of uterine endometrial cancers Ann. Onc., March 1, 2007; 18(3): 485 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N.-Y. Yang, E. B. Pasquale, L. B. Owen, and I. M. Ethell The EphB4 Receptor-tyrosine Kinase Promotes the Migration of Melanoma Cells through Rho-mediated Actin Cytoskeleton Reorganization J. Biol. Chem., October 27, 2006; 281(43): 32574 - 32586. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Chrencik, A. Brooun, M. L. Kraus, M. I. Recht, A. R. Kolatkar, G. W. Han, J. M. Seifert, H. Widmer, M. Auer, and P. Kuhn Structural and Biophysical Characterization of the EphB4{middle dot}EphrinB2 Protein-Protein Interaction and Receptor Specificity J. Biol. Chem., September 22, 2006; 281(38): 28185 - 28192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Reynolds, M. Sigaroudinia, G. Zardo, M. B. Wilson, G. M. Benton, C. J. Miller, C. Hong, J. Fridlyand, J. F. Costello, and T. D. Tlsty Tumor Suppressor p16INK4A Regulates Polycomb-mediated DNA Hypermethylation in Human Mammary Epithelial Cells J. Biol. Chem., August 25, 2006; 281(34): 24790 - 24802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Makinen, R. H. Adams, J. Bailey, Q. Lu, A. Ziemiecki, K. Alitalo, R. Klein, and G. A. Wilkinson PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature Genes & Dev., February 1, 2005; 19(3): 397 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. K. Noren, M. Lu, A. L. Freeman, M. Koolpe, and E. B. Pasquale Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth PNAS, April 13, 2004; 101(15): 5583 - 5588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Berclaz, E. Karamitopoulou, L. Mazzucchelli, V. Rohrbach, E. Dreher, A. Ziemiecki, and A.-C. Andres Activation of the receptor protein tyrosine kinase EphB4 in endometrial hyperplasia and endometrial carcinoma Ann. Onc., February 1, 2003; 14(2): 220 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Munarini, R. Jager, S. Abderhalden, G. Zuercher, V. Rohrbach, S. Loercher, B. Pfanner-Meyer, A.-C. Andres, and A. Ziemiecki Altered mammary epithelial development, pattern formation and involution in transgenic mice expressing the EphB4 receptor tyrosine kinase J. Cell Sci., January 1, 2002; 115(1): 25 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Sakamoto, M. Suga, T. Suda, and M. Ando Expression of discoidin domain receptor 1 tyrosine kinase on the human bronchial epithelium Eur. Respir. J., May 1, 2001; 17(5): 969 - 974. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Chiari, G. Hames, V. Stroobant, C. Texier, B. Maillère, T. Boon, and P. G. Coulie Identification of a Tumor-specific Shared Antigen Derived From an Eph Receptor and Presented to CD4 T Cells on HLA Class II Molecules Cancer Res., September 1, 2000; 60(17): 4855 - 4863. [Abstract] [Full Text]
|
|
